Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Europe.
Press releases published on September 7, 2025
Personal Loan Credit Insurance Market 2025-2029: Unveiling Growth Developments with the Latest Updates
EIN Presswire
·
September 7, 2025
The Business Research Company’s Personal Loan Credit Insurance Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 8, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The …
Hosted.com provides All-in-One Web Hosting Security for Improved Protection
EIN Presswire
·
September 7, 2025
Hosted.com enhances safety for online businesses with a powerful, user-friendly web hosting security suite powered by Monarx and Imunify360 CA, UNITED STATES, September 7, 2025 /EINPresswire.com/ -- Hosted.com’s all-in-one Web Hosting security system …
OYB announces the pre-launch of YLIUM utility token
EIN Presswire
·
September 7, 2025
LONDON, LONDON, UNITED KINGDOM, September 7, 2025 /EINPresswire.com/ -- Ylium, an innovative platform in the blockchain sector, is pleased to announce the pre-launch of its utility token YLIUM (YLM), designed to revolutionize the way companies, …
Money20/20 Middle East Secures Powerhouse of Founding Partners for 2025 Saudi Launch
EIN Presswire
·
September 7, 2025
RIYADH, SAUDI ARABIA, September 7, 2025 /EINPresswire.com/ -- AlRajhi Bank, Riyad Bank, STC Bank, Saudi National Bank, Tamara, Visa and Vision Bank lead a powerful coalition of financial innovators supporting the region's premier fintech gathering. …
DataGlobal Hub’s GDAI 2025 Showcases the World’s Brightest Minds in Data and AI
GlobeNewswire
·
September 7, 2025
PHOENIX, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Global Data …
Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis
GlobeNewswire
·
September 7, 2025
NEW YORK and WALTHAM, Mass., Sept. 07, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …
Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints
GlobeNewswire
·
September 7, 2025
SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …
Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora
GlobeNewswire
·
September 7, 2025
SAN FRANCISCO, Sept. 07, 2025 (GLOBE NEWSWIRE) -- El Instituto de Investigación 23andMe, Troper Wojcicki Philanthropies (TWP) y Lifebit han anunciado hoy el lanzamiento oficial de una plataforma de datos de código abierto para el Estudio genético sobre el …